Christine Elizabeth Thatcher

Title: Christine Elizabeth Thatcher: Innovator in Nanobody Technology

Introduction

Christine Elizabeth Thatcher is a prominent inventor based in Oakland, CA. She has made significant contributions to the field of biotechnology, particularly in the development of nanobody-based antibodies. Her innovative work focuses on addressing viral infections, including SARS-CoV-2.

Latest Patents

Christine holds a patent for "Multivalent anti-SARS-CoV-2 nanobodies." This patent describes asymmetric biparatopic neutralizing nanobody-based antibodies that engage the SARS-2 spike in at least two independent epitopes. Several biparatopic constructs demonstrated synergy in neutralizing viral infection of cells. The data also indicated that single biparatopic constructs are more effective than the combination of the parental monotopic constructs in terms of neutralization. The identified nanobodies bind to a single epitope that overlaps with the ACE2 binding site, showcasing their potential in therapeutic applications.

Career Highlights

Christine is currently employed at National Technology & Engineering Solutions of Sandia, LLC. Her role involves pioneering research and development in nanobody technology, contributing to advancements in medical science and public health.

Collaborations

Christine has collaborated with notable colleagues, including Yooli Kim Light and Le Thanh Mai Pham. These partnerships enhance her research efforts and foster innovation in the field.

Conclusion

Christine Elizabeth Thatcher is a trailblazer in the development of nanobody technology, with a focus on combating viral infections. Her contributions are vital to the ongoing fight against diseases like COVID-19, and her work continues to inspire advancements in biotechnology.